Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Expanded Access Protocol Lorlatinib W/ Advanced NSCLC Harboring Specific Molecular Alterations

Protocol: OSU-17258

Full Title

An Expanded Access Protocol for Lorlatinib for Treatment Of Patients With Advanced Non-Small Cell Lung Cancer Harboring Specific Molecular Alterations

Lung Cancers